More than 200 participants enrolled as company targets topline data by end of 2026 Verdiva Bio has completed enrolment for its phase 2b EVOLVE‑2 clinical study of VRB‑101, a once‑weekly oral GLP‑1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results